Robert Adams Biography and Net Worth

Robert G. Adams joined NHI as a director in May 2020. Mr. Adams was with National Healthcare Corporation (“NHC”) for 45 years. He became chairman of the board of NHC on January 1, 2009 and served as chief executive officer of NHC from November 1, 2004 until December 31, 2016. Mr. Robert Adams retired from his position as NHC CEO effective December 31, 2016 but remains non-executive Chairman of the NHC board. He has extensive long-term health care experience, including serving NHC as a healthcare center administrator and Regional Vice President. Mr. Robert Adams has a Bachelor of Science degree from Middle Tennessee State University. He also served on the board of National Health Realty, Inc. from December 1997 through October 2007.

What is Robert G. Adams' net worth?: The estimated net worth of Robert G. Adams is at least $12.58 million as of December 14th, 2022. Mr. Adams owns 180,548 shares of National Health Investors stock worth more than $12,578,779 as of December 18th. This net worth approximation does not reflect any other investments that Mr. Adams may own. Learn More about Robert G. Adams' net worth.
How do I contact Robert G. Adams?: The corporate mailing address for Mr. Adams and other National Health Investors executives is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. National Health Investors can also be reached via phone at (615) 890-9100 and via email at [email protected]. Learn More on Robert G. Adams' contact information.
Has Robert G. Adams been buying or selling shares of National Health Investors?: Robert G. Adams has not been actively trading shares of National Health Investors over the course of the past ninety days. Most recently, on Wednesday, December 14th, Robert G. Adams bought 1,000 shares of National Health Investors stock. The stock was acquired at an average cost of $56.60 per share, with a total value of $56,600.00. Following the completion of the transaction, the director now directly owns 180,548 shares of the company's stock, valued at $10,219,016.80. Learn More on Robert G. Adams' trading history.
Who are National Health Investors' active insiders?: National Health Investors' insider roster includes Robert Adams (Director), James Jobe (Director), Charlotte Swafford (Director), and Robert Webb (Director). Learn More on National Health Investors' active insiders.
Are insiders buying or selling shares of National Health Investors?: In the last year, National Health Investors insiders bought shares 2 times. They purchased a total of 10,437 shares worth more than $615,667.71. The most recent insider tranaction occured on May, 31st when Director Robert A Mccabe Jr bought 437 shares worth more than $28,767.71. Insiders at National Health Investors own 7.3% of the company. Learn More about insider trades at National Health Investors.
Information on this page was last updated on 5/31/2024.

Robert G. Adams Insider Trading History at National Health Investors

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/14/2022	Buy	1,000	$56.60	$56,600.00	180,548
8/15/2022	Buy	1,500	$65.93	$98,895.00	85,411
12/14/2020	Buy	2,000	$67.75	$135,500.00
11/17/2020	Buy	1,000	$66.45	$66,450.00
5/13/2020	Buy	425	$48.36	$20,553.00

Robert G. Adams Buying and Selling Activity at National Health Investors

National Health Investors Company Overview

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Today's Range

Now: $69.67

$69.67

$72.69

50 Day Range

MA: $76.63

$71.44

$81.57

2 Week Range

Now: $69.67

$51.59

$86.13

Volume

133,803 shs

Average Volume

199,724 shs

Market Capitalization

$3.16 billion

P/E Ratio

23.94

Dividend Yield

4.95%

Beta

1.04

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.